SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 4, 2011
STEVIA CORP.
(Exact name of registrant as specified in its charter)
Nevada 333-152365 98-0537233
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
7117 US 31 S
Indianapolis, IN 46227
(Address of principal executive offices)
(888) 250-2566
(Registrant's telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
SECTION 5 - CORPORATE GOVERNANCE AND MANAGEMENT
ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS;
APPOINTMENT OF PRINCIPAL OFFICERS.
(d) Election of Director
(i) On October 4, 2011, the Board of Directors of Stevia Corp. (the
"Company") elected Dr. Pablo Erat to the Board of Directors of the Company (the
"Board") to fill a vacancy on the Board.
Since January 2009, Dr. Erat has served as CEO of Pal & Partners AG, a
Swiss-based group domiciled in Zug with offices in Zurich and Mumbai and with a
focus on the Indian agriculture industry. Prior to joining Pal & Partners AG, in
2008 Dr. Erat served as a consultant to corporations and start-up companies in
various industries to assist in the development and implementation of innovative
strategies. In April 2001, he co-founded Executive Insight, a strategy
consulting firm and in January 2003, he co-founded DocsLogic, a company
specialized on the development of knowledge applications, where he remained
through 2007. Dr. Erat is also Assistant Professor at the ETH Zurich and
regularly delivers speeches and workshops on strategic management principles for
educational and business communities. Dr. Erat received a Doctorate from the
University of St. Gallen in Switzerland in June 2003. Dr. Erat's extensive
knowledge and experience working for and advising early stage companies as well
as his experience in the agriculture industry will be extremely relevant to the
Board.
In connection with his election to the Board, Dr. Erat will receive an
award of 1,500,000 shares of restricted common stock of the Company, which
shares will vest in annual increments of 750,000 shares.
Dr. Erat has not previously held any positions with the Company and there
are no related party transactions between the Company and Dr. Erat that are
reportable under Item 404(a) of Regulation S-K. Dr. Erat does not have any
family relationships with any director or executive officer of the Company, or
persons nominated or chosen by the Company to become directors or executive
officers. There is no arrangement or understanding between Dr. Erat and any
other persons, pursuant to which Dr. Erat was selected as a director. Except as
set forth above, there is no material plan, contract or arrangement (whether or
not written) to which Dr. Erat is a party or in which he participates that is
entered into or material amendment in connection with the Company's appointment
of Dr. Erat, or any grant or award to Dr. Erat or modification thereto, under
any such plan, contract or arrangement in connection with the Company's
appointment of Dr. Erat. Dr. Erat has not been named or, at the time of this
Current Report on Form 8-K, is not expected to be named to any committee of the
Board.
(ii) On October 6, 2011, the Company elected Rodney L. Cook to the Board to
fill a vacancy on the Board.
Mr. Cook has an extensive background in agribusiness and is a practicing
horticulturist with twenty years experience in grower education, technology
transfer from university to field, research and project development. In 2009, he
founded Ag-View Consulting, a horticulture and market development consulting
2
firm, where he remained until 2011. From 2008 to 2009, Mr. Cook has served as
Chief Executive Officer and President of Naturipe Foods, LLC a multinational
partnership of fruit growers. Prior to joining Naturipe, Mr. Cook was with
Producer Marketing Company from 1995 to 2008, where he served as Chief Executive
Officer and President. Producer Maketing was a grower owned corporation
marketing blueberries for a group of growers. Mr. Cook received a Masters of
Science, with Honor, in Horticulture from Michigan State University and a
Bachelors of Science, with Honor, in Resource Development from Michigan State
University. Mr. Cook's experience in the agriculture industry will provide
critical experience and perspective to the Company's Board of Directors.
In connection with his election to the Board, Mr. Cook will receive an
award of 1,500,000 shares of restricted common stock of the Company, which
shares will vest in annual increments of 750,000 shares.
Mr. Cook has not previously held any positions with the Company and there
are no related party transactions between the Company and Mr. Cook that are
reportable under Item 404(a) of Regulation S-K. Mr. Cook does not have any
family relationships with any director or executive officer of the Company, or
persons nominated or chosen by the Company to become directors or executive
officers. There is no arrangement or understanding between Mr. Cook and any
other persons, pursuant to which Mr. Cook was selected as a director. Except as
set forth above, there is no material plan, contract or arrangement (whether or
not written) to which Mr. Cook is a party or in which he participates that is
entered into or material amendment in connection with the Company's appointment
of Mr. Cook, or any grant or award to Mr. Cook or modification thereto, under
any such plan, contract or arrangement in connection with the Company's
appointment of Mr. Cook. Mr. Cook has not been named or, at the time of this
Current Report on Form 8-K, is not expected to be named to any committee of the
Board.
SECTION 8 - OTHER EVENTS
ITEM 8.01. OTHER EVENTS.
On October 4, 2011, the Company issued a press release announcing the
election of Dr. Erat to the Board. A copy of the press release is attached to
this report as Exhibit 99.1 and is incorporated herein by reference.
On October 6, 2011, the Company issued a press release announcing the
election of Mr. Cook to the Board. A copy of the press release is attached to
this report as Exhibit 99.2 and is incorporated herein by reference.
3
SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits
Exhibit No. Description
----------- -----------
99.1 Press Release dated October 4, 2011.
99.2 Press Release dated October 6, 2011.
The information set forth in Exhibits 99.1 and 99.2 attached hereto are
furnished and shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, and shall not be deemed incorporated by
reference in any filing with the Securities and Exchange Commission under the
Securities Exchange Act of 1934 or the Securities Act of 1933, whether made
before or after the date hereof and irrespective of any general incorporation by
reference language in any filing.
Portions of this report constitute "forward-looking statements" defined by
federal law. Although the Company believes any such statements are based on
reasonable assumptions, there is no assurance that the actual outcomes will not
be materially different. Any such statements are made in reliance on the "safe
harbor" protections provided under the Private Securities Litigation Reform Act
of 1995. Additional information about issues that could lead to material changes
in the Company's performance is contained in the Company's filings with the
Securities and Exchange Commission and may be accessed at www.sec.gov.
4
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: October 6, 2011 STEVIA CORP.
By: /s/ George Blankenbaker
----------------------------------------
George Blankenbaker
President
5